Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT00226382
First received: September 23, 2005
Last updated: June 10, 2010
Last verified: October 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)